FindTrial
Sign In

An Observational Study to Analyze the Occurrence of Respiratory Syncytial Virus Infection in Adults Following Stem Cell Transplant

Incidence of Respiratory Syncytial Virus Infection in Adults Following Haematopoietic Stem Cell Transplant

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/05/008620
Enrollment
50
Registered
2017-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sites Health Condition 2: J20-J22- Other acute lower respiratory infections Health Condition 3: null- Respiratory syncytial virus infection among adults after Haematopoietic stem cell transplant

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients must be able to give informed written consent Patients must be willing to participate in the study

Exclusion criteria

Exclusion criteria: Not willing to participate Age Not able to give informed written consent Received Palivizumab prophylaxis against RSV

Design outcomes

Primary

MeasureTime frame
Not applicable as this is an observational studyTimepoint: Not applicable as this is an observational study—

Secondary

MeasureTime frame
Not applicable as this is an observational studyTimepoint: Not applicable as this is an observational study—

Countries

India

Contacts

Public ContactSameer Abdul Samad

AIIMS New Delhi

lalitdar@gmail.com9818137078

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026